Nikola (NKLA) Stock Forum and Discussion

0.9974 +0.0261+2.69% Close 11/28 16:00 ET

0.9950-0.0024-0.24% Post 19:58 ET

1.0100High0.9214Low66.73MVolume

Nikola Stock Forum

Yozvanny 11

3 hours ago

nikola

$Nikola(NKLA.US)$ do u thinks that nikola grown tomorrow

Today’s most active stocks
$Tesla(TSLA.US)$$Palantir(PLTR.US)$$Nikola(NKLA.US)$$NIO Inc(NIO.US)$

$Nikola(NKLA.US)$ 💩

$Esperion Therapeutics(ESPR.US)$ Some great info on Esperion, its FDA approved drugs Nexletol which is Bempedoic Acid and Nexlizet drug (Bempedoic Acid and Ezetimibe) showing why Esperion will be a blockbuster.
Bempedoic acid for statin intolerant patients? This #2023 trial is the first positive outcomes trial for this lipid lowering drug — and THE FIRST to SHOW non-statin benefit in primary prevention. CLEAR Outcomes Trial, NEJM 2023
https://twitter.com/CardiacTrials/status/172595635110769067...

Fast Forward

11/17 23:46

$Nikola(NKLA.US)$ freezeeeee …….. Happy weekend

life is a blessing

11/16 08:11

$Nikola(NKLA.US)$ I recommend if you own NKLA $Cardio Diagnostics Holdings(CDIO.US)$ buy some $Esperion Therapeutics(ESPR.US)$ They trade around the same stock price, yet ESPR could jump to $4 a share in a few weeks on Judge ruling in favor for $300 million milestone for ESPR after 11/23 . Read my message article from 11/11 , This is part of it > My friend is a CVS pharmacist says now Insurance is covering ESPR drugs NEXLIZET and NEXLETOL to lower bad Cholesterol LDL-C for Statin intolerant ...